EYA2 and breast carcinoma: Moreover, we demonstrated that, through EYA2 inhibition, miR-338-3p not only suppressed breast cancer cell proliferation, EMT, migration and invasion in vitro, but also prevented breast cancer cell metastasis to lung in vivo.